Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Hunault

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Blood|August 1, 2002
Intensive therapies in follicular non-Hodgkin lymphomasMathilde Hunault-Berger, Norbert Ifrah, Philippe Solal-Celigny, et al.
Blood|March 20, 2016
Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemiaAnne Wanquet, Rudy Birsen, Richard Lemal, et al.
Leukemia Research|November 8, 2008
A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: the AFR-15 trialPatrice Chevallier, Mathilde Hunault-Berger, Fabrice Larosa, et al.
Leukemia|June 6, 2022
Evolution of eligibility criteria for non-transplant randomized controlled trials in adults with acute myeloid leukemiaCorentin Orvain, Megan Othus, Gurleen Johal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2003
Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategyCatherine Cordonnier, Agnès Buzyn, Guy Leverger, et al.
Histopathology|June 16, 2010
Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosisMaud Brousseau, Elsa Parot-Schinkel, Marie-Pierre Moles, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 25, 2026
Feasibility of tooth brushing during prolonged neutropenia in adults receiving intensive induction for acute leukemia: a randomized trialAmandine Valette, Clémence Moreau, Céline Marie, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 28, 2014
Severe viral hepatitis in a patient with chronic lymphocytic leukemia (CLL) complicated with autoimmune hemolytic anemia (AIHA), treated with steroidsCorentin Orvain, Alexandra Ducancelle, Caroline Eymerit-Morin, et al.
Ejhaem|September 2, 2022
Progressive multifocal leukoencephalopathy after durvalumab treatment for acute myeloid leukemia: A consequence of an immune reconstitution inflammatory syndrome?Emeline Vinatier, Caroline Poli, Aurélien Giltat, et al.
Clinical Immunology (Orlando, Fla.)|March 4, 2023
JAK inhibition for CD3<sup>-</sup> CD4<sup>+</sup> lymphocytic-variant hypereosinophilic syndromeStanislas Faguer, Matthieu Groh, François Vergez, et al.
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Blood|August 1, 2002
Intensive therapies in follicular non-Hodgkin lymphomasMathilde Hunault-Berger, Norbert Ifrah, Philippe Solal-Celigny, et al.
Blood|March 20, 2016
Ibrutinib responsive central nervous system involvement in chronic lymphocytic leukemiaAnne Wanquet, Rudy Birsen, Richard Lemal, et al.
Leukemia Research|November 8, 2008
A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: the AFR-15 trialPatrice Chevallier, Mathilde Hunault-Berger, Fabrice Larosa, et al.
Leukemia|June 6, 2022
Evolution of eligibility criteria for non-transplant randomized controlled trials in adults with acute myeloid leukemiaCorentin Orvain, Megan Othus, Gurleen Johal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 11, 2003
Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategyCatherine Cordonnier, Agnès Buzyn, Guy Leverger, et al.
Histopathology|June 16, 2010
Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosisMaud Brousseau, Elsa Parot-Schinkel, Marie-Pierre Moles, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 25, 2026
Feasibility of tooth brushing during prolonged neutropenia in adults receiving intensive induction for acute leukemia: a randomized trialAmandine Valette, Clémence Moreau, Céline Marie, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 28, 2014
Severe viral hepatitis in a patient with chronic lymphocytic leukemia (CLL) complicated with autoimmune hemolytic anemia (AIHA), treated with steroidsCorentin Orvain, Alexandra Ducancelle, Caroline Eymerit-Morin, et al.
Ejhaem|September 2, 2022
Progressive multifocal leukoencephalopathy after durvalumab treatment for acute myeloid leukemia: A consequence of an immune reconstitution inflammatory syndrome?Emeline Vinatier, Caroline Poli, Aurélien Giltat, et al.
Clinical Immunology (Orlando, Fla.)|March 4, 2023
JAK inhibition for CD3<sup>-</sup> CD4<sup>+</sup> lymphocytic-variant hypereosinophilic syndromeStanislas Faguer, Matthieu Groh, François Vergez, et al.
Pageof 13